The EMD Serono facility will operate with 200 scientists with proven skills in cancer biology, cancer immunotherapy, oncogene signalling, medicinal chemistry, molecular modelling, protein engineering, therapeutic antibodies and manufacturing cell lines.
-
EMD Serono's Billerica research facility is Merck KGaA's fourth R&D centre. -
The Billerica unit will focus on the discovery and development of novel... -
The EMD Serono facility will operate with 200 scientists with proven skills...
Twitter